Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Alexander Koers
Introduction
Alexander Koers is a notable inventor based in Cambridge, GB. He has made significant strides in the field of biotechnology, particularly in the development of antibody molecules. His work focuses on creating innovative solutions for medical challenges, including cancer treatment.
Latest Patents
Koers holds a patent for "Antibody molecules that bind PD-L1 and CD137." This patent describes antibody molecules that can bind both PD-L1 and CD137, inducing agonism of CD137. The invention includes a CDR-based binding site for PD-L1 and a CD137 antigen-binding site located in a constant domain of the antibody molecule. These antibody molecules have potential applications in treating diseases such as cancer, showcasing Koers' commitment to advancing medical science.
Career Highlights
Throughout his career, Alexander Koers has been associated with Invox Pharma Limited, where he has contributed to groundbreaking research and development. His expertise in antibody technology has positioned him as a key player in the biotechnology sector.
Collaborations
Koers has worked alongside talented colleagues, including Matthew Lakins and Jose Munoz-Olaya. Their collaborative efforts have further enhanced the innovative environment at Invox Pharma Limited.
Conclusion
Alexander Koers exemplifies the spirit of innovation in biotechnology through his patent and contributions to cancer treatment. His work continues to inspire advancements in medical research and development.